PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 20M 40M 60M Q3 '16: 25.1M Q4 '16: 25.7M Q1 '17: 24.9M Q2 '17: 20.1M Q3 '17: 23.5M Q4 '17: 24.9M Q1 '18: 19.4M Q2 '18: 21.6M Q3 '18: 18.2M Q4 '18: 19.5M Q1 '19: 16.4M Q2 '19: 24.6M Q3 '19: 21.9M Q4 '19: 27.9M Q1 '20: 15.6M Q2 '20: 19.1M Q3 '20: 19.1M Q4 '20: 27.1M Q1 '21: 29M Q2 '21: 30.6M Q3 '21: 34.9M Q4 '21: 36M Q1 '22: 33.2M Q2 '22: 35.5M Q3 '22: 32.3M Q4 '22: 27.4M Q1 '23: 38.9M Q2 '23: 47.6M Q3 '23: 55.7M Q4 '23: 58.4M Q1 '24: 38.8M Q2 '24: 36M Q3 '24: 40M Q4 '24: 39.2M Q1 '25: 37.2M Q2 '25: 39.8M Q3 '25: 38.4M Q4 '25: 44.6M Q1 '26: 37.2M Q2 '26: 39M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

-7M 0 7M 14M 21M Q3 '16: 12.6M Q4 '16: 11.4M Q1 '17: 8.9M Q2 '17: 8M Q3 '17: 8.2M Q4 '17: 9.5M Q1 '18: 7.3M Q2 '18: 8.9M Q3 '18: 3.2M Q4 '18: 5.7M Q1 '19: 5.1M Q2 '19: 9.6M Q3 '19: 6.9M Q4 '19: 12.9M Q1 '20: 7.5M Q2 '20: 6.6M Q3 '20: 7.1M Q4 '20: 11.4M Q1 '21: 13M Q2 '21: 13.8M Q3 '21: 15.4M Q4 '21: 16.8M Q1 '22: 14.2M Q2 '22: 16.2M Q3 '22: 13.5M Q4 '22: 5.1M Q1 '23: 9.8M Q2 '23: 15.5M Q3 '23: 17.9M Q4 '23: 9.6M Q1 '24: 11.3M Q2 '24: 5.9M Q3 '24: 10M Q4 '24: 10.1M Q1 '25: -1.4M Q2 '25: 14.7M Q3 '25: 15.9M Q4 '25: 16.6M Q1 '26: 12.8M Q2 '26: 12.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income Quarterly

-450M -300M -150M 0 150M 300M 450M Q3 '16: -16.7M Q4 '16: -17.9M Q1 '17: -23.3M Q2 '17: -24.4M Q3 '17: -21.6M Q4 '17: -20.5M Q1 '18: -23.9M Q2 '18: -21.7M Q3 '18: -24.7M Q4 '18: -30.6M Q1 '19: -30.1M Q2 '19: -24.4M Q3 '19: -28.1M Q4 '19: -17.9M Q1 '20: -32.7M Q2 '20: -23.5M Q3 '20: -24.2M Q4 '20: -24M Q1 '21: -33.7M Q2 '21: -37.6M Q3 '21: -74.5M Q4 '21: -64.7M Q1 '22: -77.5M Q2 '22: -68M Q3 '22: -74.6M Q4 '22: -87.1M Q1 '23: -91.3M Q2 '23: -73.2M Q3 '23: -82.5M Q4 '23: -87.5M Q1 '24: -81.4M Q2 '24: -175.8M Q3 '24: -64.1M Q4 '24: -153M Q1 '25: -428.9M Q2 '25: -44.9M Q3 '25: -38.9M Q4 '25: -41.2M Q1 '26: -8.4M Q2 '26: -44.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-450M -300M -150M 0 150M 300M 450M Q3 '16: -17.5M Q4 '16: -19M Q1 '17: -23.9M Q2 '17: -25.5M Q3 '17: -22M Q4 '17: -20.8M Q1 '18: -24.2M Q2 '18: -22.5M Q3 '18: -25M Q4 '18: -30.8M Q1 '19: -30.3M Q2 '19: -24.6M Q3 '19: -29.1M Q4 '19: -91K Q1 '20: 1.3M Q2 '20: -23.1M Q3 '20: -23.7M Q4 '20: 74.9M Q1 '21: -87.4M Q2 '21: -41M Q3 '21: 16.5M Q4 '21: -69.3M Q1 '22: -81.5M Q2 '22: -71.4M Q3 '22: -77M Q4 '22: -84.4M Q1 '23: -88M Q2 '23: -69.8M Q3 '23: -66.9M Q4 '23: -82M Q1 '24: -78.2M Q2 '24: -173.3M Q3 '24: -60.7M Q4 '24: 2.4M Q1 '25: -426.1M Q2 '25: -41.9M Q3 '25: -38M Q4 '25: -40.4M Q1 '26: -8.3M Q2 '26: -44.7M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 20M 40M 60M Q3 '16: 12.5M Q4 '16: 14.3M Q1 '17: 16M Q2 '17: 12.1M Q3 '17: 15.3M Q4 '17: 15.4M Q1 '18: 12.1M Q2 '18: 12.7M Q3 '18: 15M Q4 '18: 13.8M Q1 '19: 11.3M Q2 '19: 15M Q3 '19: 15M Q4 '19: 15M Q1 '20: 8.1M Q2 '20: 10.5M Q3 '20: 12M Q4 '20: 15.7M Q1 '21: 16M Q2 '21: 16.9M Q3 '21: 15.5M Q4 '21: 19.3M Q1 '22: 19M Q2 '22: 19.3M Q3 '22: 15.6M Q4 '22: 22.2M Q1 '23: 29.1M Q2 '23: 32M Q3 '23: 37.8M Q4 '23: 48.8M Q1 '24: 27.5M Q2 '24: 30.1M Q3 '24: 30M Q4 '24: 29.2M Q1 '25: 38.5M Q2 '25: 25.1M Q3 '25: 22.5M Q4 '25: 28.1M Q1 '26: 24.3M Q2 '26: 26.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-105M -70M -35M 0 35M 70M 105M Q3 '16: -15.9M Q4 '16: -12.9M Q1 '17: -16.7M Q2 '17: -12.8M Q3 '17: -17.8M Q4 '17: -20.2M Q1 '18: -18.8M Q2 '18: -14.5M Q3 '18: -14.2M Q4 '18: -19M Q1 '19: -25.3M Q2 '19: -17.6M Q3 '19: -17.3M Q4 '19: -18.2M Q1 '20: 75.4M Q2 '20: -23.8M Q3 '20: -17.8M Q4 '20: -14.3M Q1 '21: -23.1M Q2 '21: -15.7M Q3 '21: -40.7M Q4 '21: -31.7M Q1 '22: -79M Q2 '22: -60.6M Q3 '22: -63.1M Q4 '22: -60.6M Q1 '23: -94.7M Q2 '23: -41.7M Q3 '23: -65.2M Q4 '23: -57.6M Q1 '24: -75.7M Q2 '24: -54.3M Q3 '24: -45.5M Q4 '24: -30.6M Q1 '25: -44.1M Q2 '25: -29.4M Q3 '25: -18.7M Q4 '25: -19.1M Q1 '26: -44.7M Q2 '26: -35.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-105M -70M -35M 0 35M 70M 105M Q3 '16: -18.2M Q4 '16: -15.6M Q1 '17: -19.3M Q2 '17: -16.3M Q3 '17: -21.1M Q4 '17: -21.3M Q1 '18: -19.1M Q2 '18: -15.9M Q3 '18: -14.3M Q4 '18: -19M Q1 '19: -26.6M Q2 '19: -18.2M Q3 '19: -18.1M Q4 '19: -18.3M Q1 '20: 75.2M Q2 '20: -24.1M Q3 '20: -18.3M Q4 '20: -14.3M Q1 '21: -23.5M Q2 '21: -17.3M Q3 '21: -41.8M Q4 '21: -34.5M Q1 '22: -82.7M Q2 '22: -64.6M Q3 '22: -67.2M Q4 '22: -65.5M Q1 '23: -98.4M Q2 '23: -44M Q3 '23: -66M Q4 '23: -59.6M Q1 '24: -79.6M Q2 '24: -55.7M Q3 '24: -46.2M Q4 '24: -32.3M Q1 '25: -45.4M Q2 '25: -29.9M Q3 '25: -18.8M Q4 '25: -19.9M Q1 '26: -47.7M Q2 '26: -37.1M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q3 '14: 70.7M Q1 '15: 74.1M Q2 '15: 74.7M Q3 '15: 80.5M Q4 '15: 78.3M Q3 '16: 92.1M Q1 '19: 151.3M Q1 '20: 155.9M Q2 '20: 154.2M Q3 '20: 166.9M Q1 '21: 194.8M Q2 '21: 198.6M Q3 '21: 215.1M Q1 '22: 222.3M Q2 '22: 224.5M Q3 '22: 225.1M Q1 '23: 242M Q2 '23: 250.1M Q3 '23: 255M Q1 '24: 269.6M Q2 '24: 272.4M Q3 '24: 272.9M Q1 '25: 296.9M Q2 '25: 300.2M Q3 '25: 300.8M Q1 '26: 305.8M Q2 '26: 310.7M Q2 '15 Q1 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -2.00 -1.00 0.00 1.00 2.00 3.00 Q3 '16: -0.64 Q4 '16: -0.83 Q1 '17: -0.86 Q2 '17: -0.91 Q3 '17: -0.91 Q4 '17: -0.88 Q1 '18: -0.82 Q2 '18: -0.73 Q3 '18: -0.73 Q4 '18: -0.77 Q1 '19: -0.77 Q2 '19: -0.76 Q3 '19: -0.76 Q4 '19: -0.55 Q1 '20: -0.34 Q2 '20: -0.33 Q3 '20: -0.28 Q4 '20: 0.17 Q1 '21: -0.29 Q2 '21: -0.35 Q3 '21: -0.13 Q4 '21: -0.91 Q1 '22: -0.83 Q2 '22: -0.94 Q3 '22: -1.36 Q4 '22: -1.40 Q1 '23: -1.39 Q2 '23: -1.35 Q3 '23: -1.27 Q4 '23: -1.21 Q1 '24: -1.14 Q2 '24: -1.50 Q3 '24: -1.46 Q4 '24: -1.59 Q1 '25: -2.74 Q2 '25: -2.24 Q3 '25: -2.15 Q4 '25: -1.84 Q1 '26: -0.43 Q2 '26: -0.43 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.